Turn on more accessible mode
Turn off more accessible mode
Sign In
Decrease
Normal
Increase
Contrast
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
The Faculty of Medicine
Faculty of Medicine New Site
The Faculty of Medicine
oneNews
עברית
The Faculty of Medicine
Currently selected
Research
Our Science
Faculty
New Faculty Members
International PhD Students
Recent Publications
Academic Units
Research Hubs & Centers
Research Services
Recent Publications
Education
About the Faculty
Our Mission
Organization Chart
Affiliated Hospitals
Faculty Officials
Contact Us
Information For
Researchers
International Students
Prospective Students
Open Positions
Main Item 1
Main Item 2
Main Item 3
Dropdown Level 1a
Dropdown Level 2 Label
Dropdown Level 2a
Dropdown Level 2b
Dropdown Level 2c
Dropdown Level 3 Label
Dropdown Level 3a
Dropdown Level 3b
Dropdown Level 3c
Dropdown Level 2d
Dropdown Level 2e
Dropdown Level 2f
Dropdown Level 1b
Dropdown Level 1c
Dropdown Level 1d
Dropdown Level 1e
Dropdown Level 1f
See all →
Recent
Currently selected
Faculty of Medicine is proud to congratulate the faculty researchers, Prof. Rami Aqeilan, Nadav Wallis, Avanthika Venkatachalam and Hiba Natsheh, on winning the Kaye Award for Innovation
The award has been given annually since 1994 to students and faculty, administrative and technical staff of the University. Businessman Isaac Kaye, a prominent industrialist in the field of pharmaceuticals, founded the award in order to encourage faculty and students of the Hebrew University to develop innovative methods with commercial potential that will contribute to the university and society.
Congratulations to the faculty researchers on winning the Kaye Awards for Invention and Innovation:
Prof. Rami Aqeilan
- In the faculty category
Prof. Aqeilan developed a unique delivery method for gene therapy in WWOX-related human neurological diseases
Nadav Wallis
- (Yoel Israeli Laboratory, IMRIC) - in the category for students
Nadav's research in the laboratory focuses on Igf2bp1which is an Oncofetal RNA binding protein which is associated with aggressive cancers. Nadav have performed a large screen for small molecule inhibitors of igf2bp1 RNA binding, and isolated a small molecule that interacts with Igf2bp1 and inhibits binding to RNA. Inhabitation of IGF2BP1 with the small molecule shows promising results In cells and in vivo shrinking primary tumors and preventing metastases, all in the absence of any toxicity.
Avanthika Venkatachalam
- (Laboratory of Yinon Ben Neria, IMRIC) - in the category for students
The research spans a range of leukemia cell biology, from basic science to drug development with translational impact. The two primary research areas that engage me are (1) to understand and target the differences in transcription between leukemic cells and a normal blood cell and (2) developing a state-of-the-art method to visualize oncogenic features modulating drug response in cancer cells
Hiba Natsheh
- (Elka Twito Laboratory, Pharmacy) - In the student category
Hiba Natsheh, PhD is a post-doctoral fellow in Prof. Elka Touitou's laboratory at the Institute of Drug research, the Faculty of Medicine. Hiba's work focuses on nasal drug delivery to the brain. Prof. Touitou's laboratory is specialized in the design of novel drug delivery systems for dermal, transdermal and trans-mucosal administration and has generated numerous innovations with granted international patents.
×